United Kingdom  

NIH trial: Gilead's drug works best in COVID patients on oxygen

Reuters Saturday, 23 May 2020
The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc's remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.
0
shares
ShareTweetSavePostSend
 

💡 One News Page Knowledge: Other News Mentions

Gilead Sciences Gilead Sciences American pharmaceutical company

Gilead sparks Wall Street rally [Video]

Gilead sparks Wall Street rally

U.S. stocks rose Friday as a positive analysis on Gilead Sciences Inc's antiviral drug to treat COVID-19 helped to soothe investor worries over a record rise in coronavirus cases in the United States. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:20Published
Gilead says remdesivir cuts death risk [Video]

Gilead says remdesivir cuts death risk

Gilead Sciences said Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Fred Katayama reports.

Credit: Reuters Studio    Duration: 01:04Published
Gilead's remdesivir gets conditional EU clearance [Video]

Gilead's remdesivir gets conditional EU clearance

The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.

Credit: Reuters Studio    Duration: 00:59Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

Credit: Wochit News    Duration: 00:35Published
AstraZeneca shares down after report it approached Gilead [Video]

AstraZeneca shares down after report it approached Gilead

Shares in Britain's AstraZeneca opened lower on Monday after a report it had approached U.S. rival Gilead Sciences about a possible merger. Ciara Lee reports

Credit: Reuters Studio    Duration: 01:09Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Tennis tournament will be first sports event in Germany to allow fans [Video]

Tennis tournament will be first sports event in Germany to allow fans

Up to 800 people can attend each day as organisers say they will take every precaution to combat Covid-19

Credit: Reuters - Sports    Duration: 05:34Published
The migrants who come to Libya for economic opportunity [Video]

The migrants who come to Libya for economic opportunity

Caught between the fighting and COVID lockdowns, Al Jazeera meets a migrant who has come to Libya for a better life.

Credit: Al Jazeera STUDIO    Duration: 01:49Published
HM Shah praises security forces for their efforts in COVID-19 battle [Video]

HM Shah praises security forces for their efforts in COVID-19 battle

Home Minister Shah on July 12 at tree plantation drive of Central Armed Police Forces in Gurugram praised security forces for their efforts in COVID battle. "India is one of the most populous countries. Everyone thought how will a country like India battle COVID19, there were apprehensions but today the whole world is witnessing how one of the most successful battles against COVID19 has been fought here," said Union Home Minister Amit Shah."In India's battle against COVID19, all of our security forces are playing a huge role, nobody can deny it. Today, I salute these corona warriors. They have proved that they not only know how to fight terrorism but also against COVID with help of people," he further added. Union Home Minister Amit Shah participated in the 'All India Tree Plantation Campaign' run by the Central Armed Police Forces in Gurugram.

Credit: ANI    Duration: 01:47Published
COVID: Hyderabad entrepreneur develops software to track availability of beds [Video]

COVID: Hyderabad entrepreneur develops software to track availability of beds

Hyderabad-based entrepreneur Arun Varma, has developed 'covidbedavailability.in', a software to help COVID-19 patients to locate hospitals with bed availability. He said, "This solution is designed for Govt to run their war rooms, control rooms and hospitals." Objective behind the development was to help patients to easily access information. A total of 32,224 confirmed cases have been recorded in Telangana so far.

Credit: ANI    Duration: 02:08Published

You Might Like


Related videos from verified sources

New hydroxycholoroquine study results [Video]

New hydroxycholoroquine study results

Results from a new hydroxycholoroquine study show the drug did not help COVID-19 patients.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:20Published
Ask Dr. Nandi: COVID-19 Treatment Update: Blood Plasma, Hydroxychloroquine and Rheumatoid Arthritis Drug [Video]

Ask Dr. Nandi: COVID-19 Treatment Update: Blood Plasma, Hydroxychloroquine and Rheumatoid Arthritis Drug

There’s more bad news concerning Hydroxychloroquine, the drug once touted to be “one of the biggest game-changers” for COVID-19. The largest study to date found no real benefits to using this..

Credit: WXYZ Detroit     Duration: 02:55Published
Distribution of COVID-19 Treatment to Hospitals Reportedly Mismanaged by Trump Administration [Video]

Distribution of COVID-19 Treatment to Hospitals Reportedly Mismanaged by Trump Administration

A prized drug that helps treat coronavirus has reportedly seen its distribution to hospitals mishandled by the Trump administration. Veuer’s Justin Kircher has the story.

Credit: Veuer     Duration: 01:12Published

Related news from verified sources

NIH begins study of remdesivir with anti-inflammatory drug to treat COVID-19

The National Institutes of Health said on Friday it has started a clinical study to test a combination of Gilead Sciences Inc's antiviral drug remdesivir and...
Reuters


Tweets about this